Landscape of Biomarker Testing for NSCLC
Landscape of Biomarker Testing for NSCLC
Oct 2, 2024
vumedi.com
The Detection of NTRK Gene Fusions in NSCLC
The Detection of NTRK Gene Fusions in NSCLC
71 viewsOct 1, 2024
vumedi.com
Zongertinib 71% ORR for HER2-Mutant NSCLC: Key Insights from AACR 2025
1:37
Zongertinib 71% ORR for HER2-Mutant NSCLC: Key Insights from AACR 2025
1 year ago
oncologytube.com
When facing a cancer diagnosis - the small things can matter just as much as the big. Samantha is an outdoor adventurer. When she was diagnosed with HER2 (ERBB2)-mutant non-small cell lung cancer (NSCLC), her cancer journey gave her a newfound perspective on the everyday things that matter most. Learn more here: http://bit.ly/3T0csR7 #LungCancer #LifeForward | Boehringer Ingelheim
0:31
When facing a cancer diagnosis - the small things can matter just as much as the big. Samantha is an outdoor adventurer. When she was diagnosed with HER2 (ERBB2)-mutant non-small cell lung cancer (NSCLC), her cancer journey gave her a newfound perspective on the everyday things that matter most. Learn more here: http://bit.ly/3T0csR7 #LungCancer #LifeForward | Boehringer Ingelheim
1.3K views11 months ago
FacebookBoehringer Ingelheim
Samantha's journey with NSCLC is a powerful testament to resilience and the evolving landscape of cancer care. She now shares her story to spotlight the significant advancements in lung cancer treatments. Her story reminds us that even in the hardest moments, there's room for optimism. | Boehringer Ingelheim
0:17
Samantha's journey with NSCLC is a powerful testament to resilience and the evolving landscape of cancer care. She now shares her story to spotlight the significant advancements in lung cancer treatments. Her story reminds us that even in the hardest moments, there's room for optimism. | Boehringer Ingelheim
90.4K views6 months ago
FacebookBoehringer Ingelheim
Lung Cancer Basics: Biomarkers in NSCLC & NCCN Guideline Review - Part 2
Lung Cancer Basics: Biomarkers in NSCLC & NCCN Guideline Review - Part 2
38 views7 months ago
vumedi.com
Testing for ALK Rearrangements in Advanced NSCLC | OncLive
Testing for ALK Rearrangements in Advanced NSCLC | OncLive
Feb 19, 2025
onclive.com
When to Conduct Molecular Testing in NSCLC | OncLive
Nov 11, 2024
onclive.com
Dr. Larner on Integrating Radiation Therapy With Immune Checkpoint Blockade in NSCLC | OncLive
Aug 14, 2018
onclive.com
ASCO 2024 Updates: Novel Approaches in NSCLC Therapy | OncLive
Jul 22, 2024
onclive.com
Continuation of Immunotherapy Beyond Progression in Advanced NSCLC
7 months ago
medscape.com
Combination Therapy: A New Frontline Standard in the Treatment of EGFR-Mutant NSCLC | OncLive
1 year ago
onclive.com
7:39
Earn CME/CNE. Watch to learn how immunotherapy can help NSCLC patients, then complete activity: https://www.cmeuniversity.com/course/disclaimer/113314 | Society for Immunotherapy of Cancer
194.3K viewsSep 16, 2016
FacebookSociety for Immunotherapy of Cancer
Practical Application of Recent Clinical Data for Immunotherapy in NSCLC | OncLive
Oct 10, 2018
onclive.com
Dr. Clarke on the State of Biomarkers in NSCLC | OncLive
Mar 13, 2018
onclive.com
EMR Nudges to Increase Molecular Genotyping in Patients With NSCLC
9 months ago
medscape.com
HER2-Driven Strategies in Metastatic NSCLC
9 months ago
reachmd.com
Dr. Heinzerling on Remaining Challenges for Treating NSCLC | OncLive
Nov 17, 2017
onclive.com
Comprehensive Molecular Testing in Early-Stage NSCLC: Best Practices and Multidisciplinary Strategies | OncLive
Apr 16, 2025
onclive.com
Dr. Levy on Investigational Biomarkers of Response to Immunotherapy in NSCLC | OncLive
Sep 7, 2018
onclive.com
0:23
When Samantha was diagnosed with non-small cell lung cancer (NSCLC) at 37, life changed fast for her and her husband, Justin. But through it all, Justin says it’s the #BigLittleThings, the laughs, the quiet moments, the shared smiles, that mean the most. Even in hard times, those moments of joy can turn into the most cherished memories. #LifeForward #Oncology | Boehringer Ingelheim
734 views8 months ago
FacebookBoehringer Ingelheim
Application of guidelines-recommended broad molecular profiling to patients with NSCLC
Nov 26, 2024
reachmd.com
Insights from global key opinion leaders on optimizing patient care in NSCLC
Nov 26, 2024
reachmd.com
Emerging and practice-changing directions in NSCLC within the perioperative and locally advanced settings
Nov 26, 2024
reachmd.com
Resectable Early-Stage NSCLC: How the Standard of Care Is Evolving | OncLive
10 months ago
onclive.com
0:26
At 37, Samantha was diagnosed with non-small cell lung cancer (NSCLC). With support from her husband, Justin, and her care team, Samantha learned how understanding her biomarker results could help find a treatment that was right for her. Now, they’re sharing their journey to encourage others to advocate for themselves and explore testing options. “My doctor knew to give me a biomarker test, but if your doctor does not bring it up, I would highly recommend that you do because it is imperative to
549 views6 months ago
FacebookBoehringer Ingelheim
Boehringer's HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
7 months ago
financialpost.com
0:22
Boehringer Ingelheim on Instagram: "Biomarkers help explain the unique differences in how cancers grow, progress and are managed. We support @uicc_official’s @WorldCancerDay message of #UnitedByUnique, because individuality matters in cancer care. Learn what a HER2 (ERBB2) mutation means for someone with non-small cell lung cancer (NSCLC) via the link in our bio. #LifeForward"
4.3K views2 months ago
Instagramboehringer_ingelheim
8:48
Non-Small Cell Lung Cancer – An Introduction
19.8K viewsJul 3, 2018
YouTubeCancer.Net
4:05
Southern Christian Leadership Conference 50th Anniversary Video
31.9K viewsJul 15, 2011
YouTubeDiverseCityUSA1
See more